Chuanxin Biomedical (Suzhou) Co., Ltd. announced that it has received CNY 150,000,000 in a round of funding on June 29, 2023. The transaction included participation from new investor Changchun BCHT Biotechnology Co.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.15 CNY | -0.26% | -6.06% | -43.17% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.17% | 1.78B | |
+19.71% | 80.29B | |
+15.04% | 9.2B | |
-18.33% | 4.67B | |
+43.39% | 4.49B | |
+13.95% | 4.27B | |
+11.03% | 2.25B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688276 Stock
- News Changchun BCHT Biotechnology Co.
- Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.